CEP888222 Supplemental Tables - Supplemental material for Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions

Supplemental material, CEP888222 Supplemental Tables for Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions by Messoud Ashina, David Kudrow, Uwe Reuter, David Dolezil, Stephen Silberstein, Stewart J Tepper, Fei Xue, Hernan Picard, Feng Zhang, Andrea Wang, Yanchen Zhou, Frank Hong, Jan Klatt and Daniel D Mikol in Cephalalgia